Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 407 for “"CD19"”.
-
Funktionelle Charakterisierung Fc-optimierter CD19-gerichteter Antikörper
… mit Spezifität für das B-Lymphozyten spezifische CD19, eine attraktive Zielstruktur für die Therapie von akuter lymphatischer Leukämie, stellt das Fc-Engineering eine attraktive Möglichkeit dar, da der native IgG1 CD19-Antikörper kaum ADCC oder CDC gegenüber Tumorzellen vermittelt. So wurden im …
-
The Role of CD19 in Follicular Dendritic Cell Activation
… results in the loss of the FDC population. CD19-deficient mice have normal numbers of FDC containing follicles, but lack the ability to activate FDC, providing a model by which to study FDC activation. Using VCAM-1 and FcyRII/III as FDC activation markers, we show that antigen binding to FDC …
-
Efficacy of Dual Cd19-Cd79B Car In B-Cell Malignancies
… with B-cell malignancies relapse following CD19-targeting chimeric antigen receptor (CAR) T cell therapy. CD19 loss is a major cause of relapse and resistance after CD19 CAR T therapy. Dual antigen targeting could overcome resistance due to antigen escape and improve outcomes after CAR T …
-
Engineering a CD19-Based Bispecific Molecule for CAR T Cell Therapy
… availability. Conversely, conventional anti-CD19 CAR T cells can harness both healthy or malignant CD19-positive B cells for activation and expansion and thus have an abundance of available antigen. To these points, we utilized yeast-surface display and directed evolution as a pipeline for …
-
Frequenzanalyse und Subtypisierung lambda 3r-positiver CD19-positiver B-Zellen bei Magenkarzinompatienten
… Blutes auf das Vorliegen von lambda3r-positiven, CD19+B-Zellen bei Magenkarzinompatienten und Probanden unterschiedlichen Alters einige sehr interessante Ergebnisse im Bereich der B-Zellimmunität ergeben. Es scheint dabei eine Art B-Zell-Immunosurveillance in Form dieser B-Zellen, sowohl bei …
-
Ανίχνευση της σύγχρονης έκφρασης των αντιγόνων CD5/CD19 στα λεμφοκύτταρα φυσιολογικών ατόμων
… the simultaneous expression of CD5 and CD19 anti-gens in normal individuals. There are little data on international literature referring the expression of molecular markers related to chronic lymphoproliferative dis-orders in a healthy population. MATERIALS AND METHODS: 815 healthy …
-
Generation and characterization of CD19 CAR T cells with PD-1_CD28 fusion receptor
… strategy for B-ALL, adoptive T-cell transfer of CD19 targeting T cells with chimeric antigen receptor (CAR) has emerged. Clinical studies show remission rates of heavily pretreated patients of up to 90% upon CAR T-cell infusion. Despite temporary remission, around 50% of patients treated with a …
-
Targeting the CD19/CD21 complex on B cells in the mixed lymphocyte reaction
… by the B Cell Receptor (BCR) response regulator CD19/CD21 complex. This duality in B cells raises a particular interest in the case of acute graft-versus-host disease (GvHD), a common complication post allogeneic haematopoietic stem cell transplantation (HSCT). In this context, B cells may act …
-
Anti-CD19-konjugierte Zytostatika-Liposomen zur gezielten Therapie der pädiatrischen B-Zell-Leukämie
… gegen das B-Zell-spezifische Oberflächen-Antigen CD19 gerichteter monoklonaler Antikörper (αCD19) an zytostatikabeladene Liposomen gekoppelt. Zur Identifizierung einer αCD19-modifizierten Formulierung mit hoher Targeting-Effizienz und gleichzeitig stabilem Wirkstoffeinschluss, wurden …
-
EFFECT OF B CELL MODULATION VIA NON-DEPLETING ANTI-CD19 ANTIBODY ON MYOCARDIAL PHYSIOLOGY
… study, we investigated the impact of targeting CD19 on B cell function and cardiac physiology in C57BL6J mice. In vitro treatment of primary mouse splenic B cells with anti-CD19 monoclonal antibody (mAb) induced internalization of surface CD19 on mouse splenic B cells and led to a reduction in B …
-
Generation and characterization of CD19 CAR T cells with CTLA-4/CD28 fusion receptor
Adoptive transfer of CD19 specific T cells with a chimeric antigen receptor (CAR) has revolutionized anti-cancer therapy for patients with advanced B-precursor acute lymphoblastic leukemia (ALL). Unprecedented response rates up to 90% have been observed in clinical trials and resulted in FDA …
-
Chimeric ANTI-CD19 Monoclonal Antibodies for the Treatment of Precursor B Cell Acute Lymphoblastic Leukemia
… is often lost following anti-CD20 immunotherapy. CD19 is a pan B cell membrane antigen that is restricted to the B cell lineage and expressed on B cell lymphomas and pre-B ALLs. Previous studies have shown that a murine anti-human CD19 MAb, HD37, has efficacy in SCID mice with human B cell tumors. …
-
Truncated CD19 as a selection marker for the isolation of stem cell derived β-cells
… functional maturation. This is study, I explored CD19 as a potential cell surface marker for the enrichment of insulin-expressing SCβ-cells. Using CRISPR/Cas9 technology, I created a knock-in add-on of CD19-mScarlet downstream of the insulin coding sequence in human embryonic stem cells (hESCs). I …
-
Improving persistence of anti-CD19 CAR T cells via overexpression of the IL-21 receptor
Adoptive transfer of anti-CD19 chimeric antigen receptor (CAR) T cells has revolutionized the therapy of relapsed/refractory B-cell precursor ALL. High initial remission rates are nevertheless hampered by a lack of long-term persistence due to T cell exhaustion. Sustained proliferation and …
-
Phenotype of CD19 and CD56 expressing plasma cells within human bone marrow after immune response
… have described a population of BMPC lacking CD19 that express a pro-survival and distinctly mature phenotype. In order to further address the heterogeneity of human BMPC subsets, we analyzed the interrelation of CD19 and CD56 expression using both flow cytometry and single-cell RNA sequencing …
-
Untersuchung des Einflusses von Rituximab auf das Leichtkettenrepertoire bei Rheumatoider Arthritis in CD19+CD27+ B-Gedächtniszellen
… Kappa- und Lambda-Leichtkettenrepertoire der CD19+CD27+ B-Gedächtniszellen bei einer Patientin mit aktiver Rheumatoider Arthritis vor und nach B-Zell-Depletion durch Rituximab verglichen. Hierzu wurden nach der Einzelzellsortierung von mononuklären Zellen des peripheren Blutes die …
-
T cell-dependent lysis of CD19-positive leukemia cells mediated by single-chain triplebodies with dual-targeting
… for B lymphoid differentiation antigen CD19 and T cell trigger antigen CD3-epsilon – triplebody 19-3-19 – was shown to activate T lymphocytes at picomolar concentrations and to engage them for the efficient, serial lysis of target antigen-positive cancer cells. The triplebody 19-3-19 …
Page 1 of 21